Sbir topic 266 - phase II

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201100123C
Awardee
Awarding agency
Obligated
$1,000,000

Award facts

Contract value 100% obligated
$999,999.99 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Inglewood, CA 90301, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 5 · Modified to deobligate all remaining funds and administratively close the contract. -$0
Change Order 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Supplemental Agreement for work within scope 1 · Sbir topic 266 $0
Original award $1,000,000

Quick answers

Who was awarded contract HHSN261201100123C?

HHSN261201100123C was awarded to Imaginab, Inc. by National Cancer Institute (National Institutes of Health) on September 29, 2011.

How much is contract HHSN261201100123C worth?

The government has obligated $1,000,000 on HHSN261201100123C.

Was contract HHSN261201100123C competed?

The extent of competition for HHSN261201100123C was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award